Core Viewpoint - The major shareholders of MediTech plan to reduce their holdings starting from October 16, 2025, through block trades and centralized bidding, indicating potential changes in ownership structure and liquidity concerns [1] Shareholder Reduction Plans - Shareholder Weng Kang intends to reduce holdings by up to 5.21 million shares through block trades, representing 1.70% of the total share capital [1] - Additionally, Weng Kang plans to sell up to 3.06 million shares via centralized bidding, accounting for 1% of the total share capital [1] - Board member Wu Di also plans to reduce holdings by up to 14,300 shares through block trades or centralized bidding, which is 0.0047% of the total share capital [1] Source of Shares and Reasons for Reduction - The shares to be reduced by both shareholders were acquired prior to the IPO and through centralized bidding transactions [1] - The reason for the reduction is stated as personal financial arrangements for both shareholders [1] Implementation Uncertainty - The implementation of the reduction plan is noted to have uncertainties, which may affect the timing and execution of the share sales [1]
麦迪科技:两名股东拟合计减持不超1.71%公司股份